Zanubrutinib,Bendamustine,Rituximab,Venetoclax
Beigene,Roche,Abbvie
['beigene']
beigene showcases blood cancer portfolio and pipeline data at the 2023 european hematology association hybrid congress. #biotech #bgne #eha2023 #positive 
Real-time news analysis & sentiment scoring for the stocks in the Nasdaq100
Powered by @streetbeat_com of @SP500Tracker
Disclosure: https://t.co/ixCFGXlG3M